Starling Oncology (STLN) EPS (Diluted) (QoQ) (2020 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) EPS (Diluted) (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -288.86% |
| Mar 31, 2026 | 70.43% |
| Dec 31, 2025 | 50.76% |
| Sep 30, 2025 | 5.89% |
| Jun 30, 2025 | 28.00% |
| Mar 31, 2025 | -44.53% |
| Dec 31, 2024 | 17.60% |
| Sep 30, 2024 | -3.22% |
| Jun 30, 2024 | 36.69% |
| Mar 31, 2024 | -5.36% |
| Dec 31, 2023 | -7.26% |
| Sep 30, 2023 | -4.00% |
| Jun 30, 2023 | 44.18% |
| Mar 31, 2023 | -199.09% |
| Dec 31, 2022 | -306.40% |
| Sep 30, 2022 | 55.02% |
| Jun 30, 2022 | -129.53% |
| Mar 31, 2022 | 268.63% |
| Dec 31, 2021 | -1,147.66% |
| Sep 30, 2021 | 87.03% |